TXG
10X Genomics Inc
NASDAQ: TXG · HEALTHCARE · HEALTH INFORMATION SERVICES
$46.32
-1.55% today
Updated 2026-07-29
Market cap
$5.55B
P/E ratio
—
P/S ratio
8.69x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$11 – $46
Volume
3.2M
10X Genomics Inc (TXG) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$46.32
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$60.25
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.5B | $0.5B | $0.6B | $0.6B | $0.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -3.55%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.